PARP1 and neoplasm: By way of illustration, various key cellular processes in tumor development such as DNA repair, with inhibitors of Poly (ADP-Ribose) Polymerase 1 (PARP1), or the cell cycle, with inhibitors of Cyclin-Dependent Kinase (CDK) have been or are currently being studied (Supplementary Table S2).